Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P150048/S104

INSPIRIS RESILIA Aortic Valve (11500A), KONECT RESILIA Aortic Valve Conduit (AVC) (11060A), MITRIS RESILIA Mitral Valv

Edwards Lifesciences, LLC · Decision date Oct 28, 2026

MEDTECHLEDGER EXPLANATIONP150048/S104

What did the FDA decide?

The FDA record for P150048/S104 is a 30-day notice supplement, reason listed as process change affecting manufacturer, sterilizer, packager or supplier. The reported purpose is implementing an alternative supplier of a chemical manufacturing aid, linked to the INSPIRIS RESILIA aortic valve (11500A), KONECT RESILIA aortic valve conduit (AVC) (11060A) and MITRIS RESILIA mitral valve under product code LWR.

The identifier P150048 places this change within the existing PMA for the Edwards Lifesciences devices named, but the decision is a supplement, not a new approval of the whole system. The record does not identify the chemical aid, name either supplier, describe the manufacturing step, or give data on device safety or clinical performance. The purpose is reported by the applicant in the source statement and is not independent proof of safety or effectiveness.

The record carries decision code OK30 dated 2026-10-28, giving no further grounds for the decision.

FDA approval order statement

implementing an alternative supplier of a chemical manufacturing aid
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Oct 28, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P150048/S104
Regulatory pathway
PMA supplement
Product code
LWR
Decision code
OK30
Decision date
Oct 28, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: heart-valve, non-allograft tissue.

Product code
LWR
FDA device class
3

For the original device and its historical approval scope, see PMA P150048. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P150048 · Original PMA

    EDWARDS PERICARDIAL AORTIC BIOPROSTHESIS (MODEL 11000A) and EDWARDS INSPIRIS RESILIA AORTIC VALVE (MODEL 11500)

  2. P150048/S104 received

    Application receipt date recorded by FDA.

  3. P150048/S100 · Related supplement

    INSPIRIS RESILIA Aortic Valve; MITRIS RESILIA Mitral Valve

  4. P150048/S104 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P150048. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P150048

Explore the linked device profile

Other records with product code LWR

Product / regulatory recordCompanyPathwayDecision dateSource
Edwards Lifesciences, LLCPMA supplementOct 28, 2026FDA
ABBOTT MEDICALPMA supplementSep 18, 2026FDA
Edwards Lifesciences, LLCPMA approvalAug 12, 2016FDA
ABBOTT MEDICALPMA approvalAug 5, 2005FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Edwards Lifesciences, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
One Edwards Way, Irvine, CA, 92614

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records